Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

MAMMALIAN PHENOTYPE - ANNOTATIONS

The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.

Term:decreased organ/body region tumor incidence
go back to main search page
Accession:MP:0010282 term browser browse the term
Definition:less than the expected number of tumors originating in a specific body region or organ in a given population in a given time period
Synonyms:exact_synonym: decreased organ/body region tumour incidence;   reduced organ/body region tumor incidence;   reduced organ/body region tumour incidence


show annotations for term's descendants           Sort by:
 
decreased hepatoma incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr10:6,229,289...36,185,929 JBrowse link
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA RGD PMID:12154055 RGD:629566 NCBI chr 8:44,219,197...89,542,960 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA RGD PMID:12154055 RGD:629566 NCBI chr 6:86,422,697...115,379,601 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA RGD PMID:12154055 RGD:629566 NCBI chr 3:30,114,912...123,700,444 JBrowse link
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA RGD PMID:15185337 RGD:737884 NCBI chr 4:1...31,554,484 JBrowse link
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA RGD PMID:15185337 RGD:737884 NCBI chr18:53,033,494...87,080,053 JBrowse link
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:163,796,316...282,763,074 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 4:79,555,067...124,555,067 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA RGD PMID:10493520 RGD:619598 NCBI chr 8:58,425,510...106,526,740 JBrowse link
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:210,960,636...236,763,528 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:236,763,415...247,065,599 JBrowse link
Q Hcar6 Hepatocarcinoma resistance QTL 6 IDA RGD PMID:10850431 RGD:619609
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:71,476,518...116,476,518 JBrowse link
Q Hcar8 Hepatocarcinoma resistance QTL 8 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:123,478,354...168,478,354 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA RGD PMID:12154055 RGD:629566 NCBI chr 4:105,971,071...168,047,091 JBrowse link
decreased liver tumor incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:163,796,316...282,763,074 JBrowse link
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA RGD PMID:12672032 RGD:629574 NCBI chr 7:40,872,682...85,872,682 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA RGD PMID:12672032 RGD:629574 NCBI chr 1:255,728,828...282,763,074 JBrowse link
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,179,397 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:1...47,622,148 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:65,008,245...91,629,354 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:80,403,559...91,629,354 JBrowse link
decreased mammary gland tumor incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca10 Estrogen-induced mammary cancer QTL 10 IDA RGD PMID:18420736 RGD:2292503 NCBI chr 6:1,120,393...46,120,393 JBrowse link
Q Mamtr1 Mammary tumor resistance QTL 1 IAGP RGD PMID:12844486 RGD:631852 NCBI chr 5:12,651,967...117,554,267 JBrowse link
Q Mamtr2 Mammary tumor resistance QTL 2 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:5,417,336...10,246,458 JBrowse link
Q Mamtr3 Mammary tumor resistance QTL 3 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:31,224,612...43,643,900 JBrowse link
Q Mamtr4 Mammary tumor resistance QTL 4 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:14,237,830...59,237,830 JBrowse link
Q Mcs28 Mammary carcinoma susceptibility QTL 28 IAGP RGD PMID:21205740 RGD:5684388 NCBI chr 5:80,154,593...80,451,339 JBrowse link
decreased tongue tumor incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcat1 Tongue tumor resistance QTL 1 QTM RGD PMID:9563479 RGD:61091 NCBI chr 1:111,446,783...156,446,783 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  mammalian phenotype 4987
    neoplasm 229
      altered tumor susceptibility 222
        abnormal tumor incidence 211
          abnormal organ/body region tumor incidence 183
            decreased organ/body region tumor incidence 51
              decreased alimentary system tumor incidence + 2
              decreased cardiovascular system tumor incidence 0
              decreased eye tumor incidence 0
              decreased gland tumor incidence + 26
              decreased hemolymphoid system tumor incidence + 0
              decreased hepatobiliary system tumor incidence + 23
              decreased integument system tumor incidence + 26
              decreased lung tumor incidence 0
              decreased muscle tumor incidence + 0
              decreased nervous system tumor incidence 0
              decreased reproductive system tumor incidence + 0
              decreased respiratory system tumor incidence 0
              decreased reticular tumor incidence + 0
              decreased skeletal tumor incidence 0
              decreased urinary system tumor incidence 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.